nach oben

Clinical and Experimental Nephrology

Erschienen in:

01.08.2009 | Review Article

Nocturnal hemodialysis

verfasst von: Paramjit Kalirao, Joshua M. Kaplan

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

With the increasing number of patients with end stage renal disease comes an increasingly urgent need for renal replacement therapy that is both clinically effective and cost effective. This article explores some of the advantages of nocturnal hemodialysis as well as some of the barriers to its use.

Sheldon S. Independence in maintenance haemodialysis. Lancet. 1968; 1:520.CrossRef

Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol. 1998;9:859–68.PubMed

Uldall PR, Francoeur R, Ouwendyk M. Simplified nocturnal home hemodialysis. A new approach to renal replacement therapy. J Am Soc Nephrol. 1994;5:42.

Blagg CR. A brief history of home hemodialysis. Adv Renal Replace Ther. 1996;3:99–105.CrossRef

Suri R, Depner TA, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis. 2003;42:S42–8.CrossRef

Pierratos A. New approaches to hemodialysis. Annu Rev Med. 2004;55:179–89.CrossRefPubMed

United States Renal Data System—USRDS. 2003. Mortality and causes of death. http://www.usrds.org/2002/pdf/h.pdf.

United States Renal Data System. Excerpts from USRDS 2005 Annual Data Report. U.S. Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 2006; 47(Suppl 1):S1.

O’Seaghdha CM, Foley RN. Septicemia, access, cardiovascular disease, and death in dialysis patients. Perit Dial Int. 2005;25(6):534–40.PubMed

10.

Buzello M, Tornig J, Faulhaber J, Ehmke H, et al. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol. 2003;14(2):311–6.CrossRefPubMed

11.

Bro S, Bentzon JF, Falk E, et al. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol. 2003;14(10):2466–74.CrossRefPubMed

12.

Yuen D, Pierratos A, Richardson RMA, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplantation. 2006;21:1407–12.CrossRef

13.

Ottonello L, Gnerre P, et al. Leptin as a Uremic Toxin Interferes with Neutrophil chemotaxis. J Am Soc Nephrol. 2004;15:2366–72.CrossRefPubMed

14.

Pierratos A, McFarlane P, Chan CT. Quotidian dialysis–update 2005. Curr Opin Nephrol Hypertens. 2005;14:119–24.CrossRefPubMed

15.

Pierratos A. Daily nocturnal home hemodialysis. Kidney International. 2004;65:1975–86.CrossRefPubMed

16.

Gotch FA. Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens? Semin Dial. 2001;14:15–7.CrossRefPubMed

17.

Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–9.CrossRefPubMed

18.

Clark WR, Leypoldt JK, Henderson LW, et al. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol. 1999;10:601–9.PubMed

19.

Raj DS, Ouwendyk M, Francoeur R, et al. B2-microglobulin kinetics in nocturnal hemodialysis. Nephrol Dial Transplant. 2000;15:58–64.CrossRefPubMed

20.

Mucsi I, Hercz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998;53:1399–404.CrossRefPubMed

21.

Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorous and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607–17.CrossRefPubMed

22.

Pierratos A, Hercz G, Sherrard DJ, et al. Calcium, phosphorous metabolism and bone pathology on long term nocturnal hemodialysis. J Am Soc Nephrol. 2001;12:274. (abstract).

23.

Kim SJ, Goldstein M, Szabo T, et al. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis. 2003;41:12.CrossRef

24.

Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States AJKD. 2002;40(6):1202–10.PubMed

25.

Yeboah J, Crouse JR, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults. The Cardiovascular Health Study. Circulation. 2004;109:613–9.CrossRef

26.

Ghiadoni L, Cupisti A, et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol. 2004;17:512–9.PubMed

27.

Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London G. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int. 2000;57:1091–9.CrossRefPubMed

28.

Passauer J, Pitrosch F, et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. JASN. 2005;16:959–65.CrossRefPubMed

29.

Chan CT, Harvey PJ, et al. Short-term blood pressure, noradrenergic and vascular effects of nocturnal home hemodialysis. Hypertension. 2003;42(5):925–31.CrossRefPubMed

30.

Lindsay RM. The London, Ontario, Daily/Nocturnal Hemodialysis Study. Semin Dial. 2004;17(2):85–91.CrossRefPubMed

31.

Culleton BF, Walsh M, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA. 2007;298(11):1291–9.CrossRefPubMed

32.

Chan CT, Notarius CF, et al. Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant. 2007;22(11):3285–91.CrossRefPubMed

33.

Fong E, Bargman JM, et al. Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home hemodialysis versus peritoneal dialysis. Clin J Am Soc Nephrol. 2007;2:1195–200.CrossRefPubMed

34.

Elder SJ, Pisoni RL, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008;23(3):998–1004.CrossRefPubMed

35.

Kocak H, Ly J, Chan CT. Improvement in open angle glaucoma by nocturnal home haemodialysis. Neph Dialy Transp. 2006;21(9):2647–9.CrossRef

36.

Jassal SV, Devins GM, et al. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int. 2006;70(5):956–62.CrossRefPubMed

37.

Lynn KL, Buttimore J, Wells JE, et al. Long-term survival of arteriovenous fistulas in home hemodialysis patients. Ki dney International. 2004;65:1890–6.CrossRef

38.

McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney International. 2002;62:2216–22.CrossRefPubMed

39.

Diaz-Buxo JA, Schlaeper C, VanValkenburgh D. Evolution of home hemodialysis monitoring systems. Hemodial Int. 2003;7:353–5.CrossRefPubMed

40.

Heidenheim AP, Leitch R, Kortas C, Lindsay RM. Patient monitoring in the London daily/nocturnal hemodialysis study. Am J Kidney Dis. 2003;42:61–5.CrossRefPubMed

41.

Rodriguez HJ, Domenici R, Diroll A, Goykhman I. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney International. 2005;68:854–61.CrossRefPubMed

42.

Jaeger JQ, Mehta RL. Assessment of Dry Weight in Hemodialysis: An Overview. J Am Soc Nephrol. 1999;10:392–403.PubMed

43.

Ayus JC, Mizani MR, et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005;16(9):2778–88.CrossRefPubMed

Titel: Nocturnal hemodialysis
verfasst von: Paramjit Kalirao
Joshua M. Kaplan
Publikationsdatum: 01.08.2009
Verlag: Springer Japan
Erschienen in: Clinical and Experimental Nephrology / Ausgabe 4/2009
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-008-0110-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Evaluation of a new automated, enzymatic inulin assay using d-fructose dehydrogenase

Ultrasonography as a predictor of overt bleeding after renal biopsy

Pathological influence of obesity on renal structural changes in chronic kidney disease

Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients

A case of Mikulicz’s disease complicated with severe interstitial nephritis associated with IgG4